Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06796634

Effects of Cold Atmospheric Plasma (CAP) on Peritoneal Tumor Tissue

Led by University Hospital, Ghent · Updated on 2025-01-28

5

Participants Needed

1

Research Sites

31 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

There are to date no studies available that have examined the effects of CAP on tumor tissue in patients. The aim of this study is to investigate these effects in patients undergoing surgery for peritoneal metastases. Tumor nodules will be treated with different durations and intensities of CAP before being surgically removed. The resected nodules will be analyzed for tumor vitality.

CONDITIONS

Official Title

Effects of Cold Atmospheric Plasma (CAP) on Peritoneal Tumor Tissue

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with peritoneal metastases undergoing surgery (CRS, debulking), irrespective of the origin
  • Written informed consent
  • Age 18 years or older
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

UZ Ghent

Ghent, East-Flanders, Belgium, 9000

Actively Recruiting

Loading map...

Research Team

W

Wim Ceelen, professor

CONTACT

S

Sarah Cosyns, doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here